首页> 美国政府科技报告 >Pharmacokinetics of Benzoic Acid, 2-Chloro-5-(((5,6-Dihydro-2-Methyl-1,4-Oxathiin-3-YL)Carbonyl)Amino)-1- Methylethyl Ester (NSC-D615985) in Rats.
【24h】

Pharmacokinetics of Benzoic Acid, 2-Chloro-5-(((5,6-Dihydro-2-Methyl-1,4-Oxathiin-3-YL)Carbonyl)Amino)-1- Methylethyl Ester (NSC-D615985) in Rats.

机译:苯甲酸,2-氯-5 - (((5,6-二氢-2-甲基-1,4-氧硫杂环己烷-3-YL)羰基)氨基)-1-甲基乙基酯(NsC-D615985)在大鼠体内的药代动力学。

获取原文

摘要

In the study, male Fischer 344 rats were intravenously, intraperitoneally, or orally administered NSC-D615985 which was formulated in 20 percent Liposyn II at dose levels ranging from 10 to 750 mg/kg body weight. Blood was collected for plasma drug concentration analysis at the following time-points after dosing: 2, 5, 15, 30, 60, 90, 120, and 180 minutes. For the intravenous group, plasma levels decreased from approximately 7.6 microgram/mL at 2 minutes after dosing to less than 1 microgram/mL at 15 minutes after dosing and were undetectable at lower concentrations up to 90 minutes after treatment. No detectable levels of the test article were observed in the plasma of rats at any time-point following intraperitoneal or oral treatment (100 mg/kg and 750 mg/kg, respectively).

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号